| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 03/01/2005 | US6861424 A piperazine compound as antithrombotic agent |
| 03/01/2005 | US6861421 Nociceptin analogs |
| 03/01/2005 | US6861419 Substituted 1, 4-thiazepine and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 03/01/2005 | US6861418 Modulating protein kinase signal transduction; anticancer agents |
| 02/24/2005 | WO2005016922A1 Carbazole-2-carboxamide derivatives having vanilloid receptor antagonist activity |
| 02/24/2005 | WO2005016920A1 Pyrrole compositions useful as inhibitors of c-met |
| 02/24/2005 | WO2005016919A1 Aminopyrones and their use as atm inhibitors |
| 02/24/2005 | WO2005016918A2 Heterocyclic n-aryl carboxamides as cytokine inhibitors |
| 02/24/2005 | WO2005016915A1 Piperidine/cyclohexane carboxamide derivatives for use as vanilloid receptor modulators |
| 02/24/2005 | WO2005016914A1 Chemical compounds |
| 02/24/2005 | WO2005016911A1 4-pyrimidone derivatives and their use as peptidyl peptidase inhibitors |
| 02/24/2005 | WO2005016893A2 2,4-pyrimidinediamine compounds for use in the treatment or prevention of autoimmune diseases |
| 02/24/2005 | WO2005016892A1 Gabanergic modulators |
| 02/24/2005 | WO2005016888A1 Probe for diseases wth amyloid accumulation, amyloid-staining agent, remedy and preventive for diseases with amyloid accumulation and diagnostic probe and staining agent for neurofibrillary change |
| 02/24/2005 | WO2005016886A1 Sulfonyl substituted n-(biarylmethyl) aminocyclopropanecarboxamides |
| 02/24/2005 | WO2005016883A2 Acrylamide derivatives as vla-1 integrin antagonists and uses thereof |
| 02/24/2005 | WO2005016879A2 Cyclic pyrazinoylguanidine sodium channel blockers |
| 02/24/2005 | WO2005016862A1 Substituted arylalkanoic acid derivative and use thereof |
| 02/24/2005 | WO2005016384A1 Probe for disease with amyloid deposit, amyloid-staining agent, remedy and preventive for disease with amyloid deposit and diagnostic probe and staining agent for neurofibril change |
| 02/24/2005 | WO2005016346A1 Quinazoline analogs as receptor tyrosine kinase inhibitors |
| 02/24/2005 | WO2005016326A2 Analogs of thalidomide as potential angiogenesis inhibitors |
| 02/24/2005 | WO2005016325A2 CRISTALLINE ZIPRASIDONE HCl AND PROCESSES FOR PREPARATION THEREOF |
| 02/24/2005 | WO2004099168A3 Substituted carboxylic acids |
| 02/24/2005 | WO2004094395A3 Biaryl substituted thiazoles, oxazoles and imidazoles as sodium channel blockers |
| 02/24/2005 | WO2004093789A3 Use of galr3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods |
| 02/24/2005 | WO2004046103A3 Arylpyridine compounds |
| 02/24/2005 | WO2003002062A3 Bis-aryl thiazole derivatives |
| 02/24/2005 | US20050043545 4-(5-Membered)-heteroaryl acyl pyrrolidine derivatives as hcv inhibitors |
| 02/24/2005 | US20050043539 (Rosiglitazone maleate); Purifying 5-[4-[2-[N-methyl-N-(2-pyridyl)amino]ethoxy]benzylidene]thiazolidine-2,4-dione in an alcoholic solvent, reduction with a metal complex and reducing agent, purification with alcoholic ammonia, maleate salt formation; improved purity; industiral scale; antidiabetic agents |
| 02/24/2005 | US20050043397 Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
| 02/24/2005 | US20050043390 Viricides against herpes virus |
| 02/24/2005 | US20050043388 Therapy, prevention of metabolism disorders; insulin resistance; antidiabetic agents; hypoglycemic agents; anticholesterol agents; obesity; polycystic ovarian syndrome |
| 02/24/2005 | US20050043381 Aminopyrazole compounds |
| 02/24/2005 | US20050043379 Leukotriene hydrolase inhibitors; antiinflammatory agents; antihistamines; chronic onstructive pulmonary disorders; atherosclerosis; multiple sclerosis; inflammatory bowel disorders; antiarthritic agents ;psoriasis |
| 02/24/2005 | US20050043378 LTA4H modulators |
| 02/24/2005 | US20050043376 Epothilone A and B; desoxyepothilone A and B; anticancer agenst |
| 02/24/2005 | US20050043374 Administering to animal drug , or hydrolysable ester thereof |
| 02/24/2005 | US20050043368 Osteoporosis therapy; bone disorders |
| 02/24/2005 | US20050043360 Method for obtaining pioglitazone as an antidiabetic agent |
| 02/24/2005 | US20050043357 Mitotic kinesin inhibitors |
| 02/24/2005 | US20050043336 Quinazoline derivatives as antitumor agents |
| 02/24/2005 | US20050043334 Such as N6-(4,5-dihydrooxazol-2-yl)-N4-[3-methyl-4-(6-methylpyridin-3-yloxy)-phenyl]-quinazoline-4,6-diamine; for treatment of hyperproliferative disorders such as cancer |
| 02/24/2005 | US20050043330 Antiinflammation agents |
| 02/24/2005 | US20050043326 Compounds |
| 02/24/2005 | US20050043324 Polymorphic forms of ziprasidone HCI and processes for their preparation |
| 02/24/2005 | US20050043317 Biaryl heterocyclic compounds and methods of making and using the same |
| 02/24/2005 | US20050043313 1-(phenylaminocarbonylmethyl)-3-alkylamino-5,6-disubstituted-2-pyazinones; serine protease inhibitors; anticoagulants; coronary artery and cerebrovascular diseases |
| 02/24/2005 | US20050043302 New indole derivatives as factor Xa inhibitors |
| 02/24/2005 | US20050043299 Inhibitors of dipeptidyl peptidase iv |
| 02/24/2005 | US20050043290 for treating neurodegenerative disease such as Alzheimer's disease |
| 02/24/2005 | US20050043242 Using dietary restriction to lower serum insulin levels and function along with troglitazone in treatment and prevention of alzheimer's diseases |
| 02/24/2005 | US20050042674 Combinatorial libraries |
| 02/24/2005 | US20050042407 containing a cyanovinylene group; can be written on or read by blue light, preferably laser light |
| 02/24/2005 | DE10331004A1 Verfahren für die Herstellung von C1-C15-Fragmenten von Epothilonen und deren Derivaten A process for the preparation of C1-C15-fragments of epothilones and derivatives thereof |
| 02/24/2005 | DE102004010545A1 Pyrazoline Pyrazolines |
| 02/24/2005 | CA2536470A1 Pyrrole compositions useful as inhibitors of c-met |
| 02/24/2005 | CA2535665A1 Substituted arylalkanoic acid derivative and use thereof |
| 02/24/2005 | CA2535619A1 4-pyrimidone derivatives and their use as peptidyl peptidase inhibitors |
| 02/24/2005 | CA2535406A1 Gabanergic modulators |
| 02/24/2005 | CA2534300A1 Aminopyrones and their use as atm inhibitors |
| 02/24/2005 | CA2528192A1 Cristalline ziprasidone hcl and processes for preparation thereof |
| 02/24/2005 | CA2518774A1 Heterocyclic n-aryl carboxamides as cytokine inhibitors |
| 02/24/2005 | CA2500358A1 Probes for diseases in which amyloid accumulates, agents for staining amyloid, drugs for treatment and prophylaxis of diseases with accumulated amyloid, and probes for diagnosis of neurofibrillary tangles and agents for staining neurofibrillary tangles |
| 02/23/2005 | EP1507776A1 2-oxo-1,3,4-trihydroquinazolinyl derivatives for the treatment of cell proliferation-related disorders |
| 02/23/2005 | EP1507772A1 Methods of using thiazolidinedithione derivatives |
| 02/23/2005 | EP1507762A1 Pesticidal pyridinecarboxamide derivatives |
| 02/23/2005 | EP1507761A1 Pyridine carboxamide derivatives and their use as pesticides |
| 02/23/2005 | EP1507534A2 Compounds, compositions and methods |
| 02/23/2005 | EP1507530A1 Diaminothiazoles |
| 02/23/2005 | EP1261606B1 Substituted oxazolidinones and their use in the field of blood coagulation |
| 02/23/2005 | EP1133482B1 Il-5 inhibiting 6-azauracil derivatives |
| 02/23/2005 | CN1585768A Pyrazole derivatives as psychopharmaceuticals |
| 02/23/2005 | CN1585763A Piperidine derivatives and their use as modulators of chemokine receptor activity especially CCR5 |
| 02/23/2005 | CN1585754A Quinazoline derivatives as antitumor agents |
| 02/23/2005 | CN1585752A 4, 4-difluoro-1, 2, 3, 4-tetrahydro-5H-1-benzazepine derivatives or salts thereof |
| 02/23/2005 | CN1585747A Azetidinyl diamines useful as ligands of the nociceptin receptor ORL-1 |
| 02/23/2005 | CN1585643A Benzotriazepines as gastrin and cholecystokinin receptor ligands |
| 02/23/2005 | CN1585639A Antimalarial agents |
| 02/23/2005 | CN1585636A Use of endothelin receptor antagonists in the treatment of tumour diseases |
| 02/23/2005 | CN1190434C Novel heterocyclic compounds and process for its preparation, and pharmaceutical compositions containing them and their use in treatment of diabetes and related diseases |
| 02/23/2005 | CN1190424C Quinoline-containing Alpha-ketoamide cysteine and serine protease inhibitors |
| 02/22/2005 | US6858741 Use as pesticides and herbicides |
| 02/22/2005 | US6858740 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses |
| 02/22/2005 | US6858642 For use in pharmaceutical, skin-protective and cosmetic formulations |
| 02/22/2005 | US6858628 Substituted cyclic amine metalloprotease inhibitors |
| 02/22/2005 | US6858626 Cyclic hydroxamic acid as metalloproteinase inhibitors |
| 02/22/2005 | US6858611 Antiarrhythmia agents; cardiovascular disorders |
| 02/22/2005 | US6858610 Autoimmune disease; antiinflammatory agents |
| 02/22/2005 | US6858605 Substituted 2,3-benzodiazepine derivatives |
| 02/22/2005 | US6858603 Acetindine derivatives, their preparation and medicaments containing them |
| 02/22/2005 | US6858594 Compounds and methods for treating urinary incontinence |
| 02/22/2005 | US6858411 Recombinant nucleic acids that encode epothilone polyketide synthase (PKS) are used to express recombinant PKS genes in host cells to produce epothilone derivatives/polyketides; used as cancer drugs, fungicides and immunosuppressants |
| 02/22/2005 | CA2218493C Benzimidazole compounds and their use as modulators of the gabaa receptor complex |
| 02/17/2005 | WO2005015215A1 Novel chemiluminescent compounds and their use |
| 02/17/2005 | WO2005014593A1 Thiazole derivatives as npy antagonists |
| 02/17/2005 | WO2005014592A1 2-amino-5-benzoylthiazole npy antagonists |
| 02/17/2005 | WO2005014591A1 2-acylamino or 2-sulfonylamino-1, 3-thiazoles as couplers for the oxidation dyeing of keratin fibres |
| 02/17/2005 | WO2005014579A1 Imidazol derivatives of piperdine as histamine antagonists |
| 02/17/2005 | WO2005014578A1 Phenylsulfonyl compounds as antipsychotic agents |
| 02/17/2005 | WO2005014554A1 1h-indazole-3-carboxamide compounds as mapkap kinase modulators |